Integrated Molecular Profiling in Advanced Cancers Trial (IMPACT)
This study is not yet open for participant recruitment.
Verified February 2012 by University Health Network, Toronto
First Received on January 4, 2012. Last Updated on February 16, 2012 History of Changes
Primary Outcome Measures: Molecular profiling data to be made available in patient's electronic medical records. [ Time Frame: 1 month ] [ Designated as safety issue: No ]
Primary Outcome Measures: Molecular profiling data to be made available in patient's electronic medical records. [ Time Frame: 1 month ] [ Designated as safety issue: No ]
Genotyping
assays including:
AKT1, HRAS, AKT2, JAK2, AKT3, KIT, BRAF, KRAS, CDK,
MEK1, CTNNB1, MET, EGFR, NOTCH1, ERBB2, NRAS, FGFR1, PDGFRA, FGFR2,
PIK3CA, FGFR3, RET, FGFR4, SMO, STK11